Advertisement
Screener

10x Genomics, Inc. (TXG) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

10x Genomics, Inc. Increase (Decrease) in Accounts Receivable

10x Genomics, Inc. (TXG) reported Increase (Decrease) in Accounts Receivable of $534.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-07

  • 10x Genomics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $8.51M.
  • 10x Genomics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$7.98M.
  • 10x Genomics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $3.23M, a 26.04% decline year-over-year.
  • 10x Genomics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$6.63M.
  • 10x Genomics, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$41.31M.
  • 10x Genomics, Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$26.95M, a 353.94% decline from fiscal 2023.
  • 10x Genomics, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $10.61M, a 43.99% decline from fiscal 2022.
  • 10x Genomics, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $18.95M, a 44.34% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 12 month
2026-06-30$8.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$534.00K
10-Q · filed 2026-08-07
$3.77M
derived: sum of 3 quarters · filed 2026-08-07
-$2.86M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31-$7.98M
10-Q · filed 2026-05-08
-$4.75M
derived: sum of 2 quarters · filed 2026-05-08
-$11.38M
derived: sum of 3 quarters · filed 2026-05-08
-$13.97M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$3.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
-$3.40M
derived: sum of 2 quarters · filed 2026-02-13
-$5.99M
derived: sum of 3 quarters · filed 2026-08-07
-$41.31M
10-K · filed 2026-02-13
2025-09-30-$6.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$9.22M
derived: sum of 2 quarters · filed 2026-08-07
-$44.55M
10-Q · filed 2025-11-07
-$40.18M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30-$2.59M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$37.92M
10-Q · filed 2026-08-07
-$33.55M
derived: sum of 3 quarters · filed 2026-08-07
-$41.23M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$35.33M
10-Q · filed 2026-05-08
-$30.95M
derived: sum of 2 quarters · filed 2026-05-08
-$38.64M
derived: sum of 3 quarters · filed 2026-05-08
-$38.76M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$4.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
-$3.31M
derived: sum of 2 quarters · filed 2026-02-13
-$3.44M
derived: sum of 3 quarters · filed 2026-02-13
-$26.95M
10-K · filed 2026-02-13
2024-09-30-$7.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$7.80M
derived: sum of 2 quarters · filed 2025-11-07
-$31.32M
10-Q · filed 2025-11-07
-$20.35M
derived: sum of 4 quarters · filed 2026-02-13
2024-06-30-$122.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
-$23.64M
10-Q · filed 2025-08-08
-$12.66M
derived: sum of 3 quarters · filed 2026-02-13
$3.50M
derived: sum of 4 quarters · filed 2026-02-13
2024-03-31-$23.52M
10-Q · filed 2025-05-09
-$12.54M
derived: sum of 2 quarters · filed 2026-02-13
$3.62M
derived: sum of 3 quarters · filed 2026-02-13
$13.38M
derived: sum of 4 quarters · filed 2026-02-13
2023-12-31$10.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$27.14M
derived: sum of 2 quarters · filed 2026-02-13
$36.89M
derived: sum of 3 quarters · filed 2026-02-13
$10.61M
10-K · filed 2026-02-13
2023-09-30$16.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
$25.92M
derived: sum of 2 quarters · filed 2024-10-29
-$361.00K
10-Q · filed 2024-10-29
$20.26M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$9.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$16.53M
10-Q · filed 2024-08-08
$4.09M
derived: sum of 3 quarters · filed 2025-02-13
$11.45M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31-$26.28M
10-Q · filed 2024-04-30
-$5.66M
derived: sum of 2 quarters · filed 2025-02-13
$1.69M
derived: sum of 3 quarters · filed 2025-02-13
$1.40M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$20.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$27.97M
derived: sum of 2 quarters · filed 2025-02-13
$27.68M
derived: sum of 3 quarters · filed 2025-02-13
$18.95M
10-K · filed 2025-02-13
2022-09-30$7.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$7.05M
derived: sum of 2 quarters · filed 2023-11-03
-$1.67M
10-Q · filed 2023-11-03
$5.15M
derived: sum of 4 quarters · filed 2024-02-15
2022-06-30-$297.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
-$9.03M
10-Q · filed 2023-08-04
-$2.20M
derived: sum of 3 quarters · filed 2024-02-15
$17.19M
derived: sum of 4 quarters · filed 2024-02-15
2022-03-31-$8.73M
10-Q · filed 2023-05-04
-$1.90M
derived: sum of 2 quarters · filed 2024-02-15
$17.49M
derived: sum of 3 quarters · filed 2024-02-15
$19.12M
derived: sum of 4 quarters · filed 2024-02-15
2021-12-31$6.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15
$26.22M
derived: sum of 2 quarters · filed 2024-02-15
$27.85M
derived: sum of 3 quarters · filed 2024-02-15
$34.04M
10-K · filed 2024-02-15
2021-09-30$19.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$21.03M
derived: sum of 2 quarters · filed 2022-11-03
$27.22M
10-Q · filed 2022-11-03
$42.41M
derived: sum of 4 quarters · filed 2023-02-16
2021-06-30$1.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$7.82M
10-Q · filed 2022-08-09
$23.02M
derived: sum of 3 quarters · filed 2023-02-16
$36.32M
derived: sum of 4 quarters · filed 2023-02-16
2021-03-31$6.19M
10-Q · filed 2022-05-05
$21.38M
derived: sum of 2 quarters · filed 2023-02-16
$34.68M
derived: sum of 3 quarters · filed 2023-02-16
$26.56M
derived: sum of 4 quarters · filed 2023-02-16
2020-12-31$15.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$28.49M
derived: sum of 2 quarters · filed 2023-02-16
$20.37M
derived: sum of 3 quarters · filed 2023-02-16
$17.85M
10-K · filed 2023-02-16
2020-09-30$13.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$5.17M
derived: sum of 2 quarters · filed 2021-11-05
$2.65M
10-Q · filed 2021-11-05
$9.88M
derived: sum of 4 quarters · filed 2022-02-18
2020-06-30-$8.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
-$10.65M
10-Q · filed 2021-08-06
-$3.42M
derived: sum of 3 quarters · filed 2022-02-18
-$4.00M
derived: sum of 4 quarters · filed 2022-02-18
2020-03-31-$2.52M
10-Q · filed 2021-05-07
$4.70M
derived: sum of 2 quarters · filed 2022-02-18
$4.12M
derived: sum of 3 quarters · filed 2022-02-18
$5.44M
derived: sum of 4 quarters · filed 2022-02-18
2019-12-31$7.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18
$6.64M
derived: sum of 2 quarters · filed 2022-02-18
$7.96M
derived: sum of 3 quarters · filed 2022-02-18
$5.28M
10-K · filed 2022-02-18
2019-09-30-$578.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$736.00K
derived: sum of 2 quarters · filed 2020-11-12
-$1.94M
10-Q · filed 2020-11-12
$7.05M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$1.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
-$1.36M
10-Q · filed 2020-08-12
$7.63M
derived: sum of 3 quarters · filed 2021-02-26
2019-03-31-$2.67M
10-Q · filed 2020-05-12
$6.32M
derived: sum of 2 quarters · filed 2021-02-26
2018-12-31$8.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$14.75M
10-K · filed 2021-02-26
2018-09-30$5.76M
10-Q · filed 2019-11-12
2017-12-31$5.13M
10-K · filed 2020-02-27